A change in the density of [3H]flumazenil, but not [3H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder

Journal of Affective Disorders

Volumn 66, Issue 2-3, 2001, Pages 147-158

  Dean, Brian ^a,b,c   Pavey, Geoffrey ^a   McLeod, Mark ^a,b   Opeskin, Kenneth ^a   Keks, Nicholas ^a,c   Copolov, David ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Bipolar disorder; GABA; GABAA receptor; Glutamate; Schizophrenia; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMITRIPTYLINE; BENZATROPINE; BENZODIAZEPINE; BIOCHEMICAL MARKER; BRAIN RECEPTOR; CARBAMAZEPINE; CHLORPROMAZINE; CLONAZEPAM; DOSULEPIN; FLUMAZENIL; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; IONOTROPIC RECEPTOR; LITHIUM; MIDAZOLAM; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRAZEPAM; NORTRIPTYLINE; OXAZEPAM; PROCYCLIDINE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TEMAZEPAM; TRIHEXYPHENIDYL; UNINDEXED DRUG; VALPROIC ACID;

ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN TISSUE; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; FRONTAL LOBE; HUMAN; HUMAN TISSUE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AGED; AUTORADIOGRAPHY; BIPOLAR DISORDER; BRAIN MAPPING; FEMALE; FLUMAZENIL; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; MUSCIMOL; RADIOLIGAND ASSAY; RECEPTORS, GABA-A; SCHIZOPHRENIA;

EID: 0034802824     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00294-9     Document Type: Article

References (42)

1. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients
2. 2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro
3. Neurotransmitter receptors in frontal cortex of schizophrenics
4. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: Effect of lithium carbonate
5. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia
6. 3H]Paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia
7. Decreased frontal cortical serotonin2A receptors in subjects with schizophrenia
8. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain
9. Changes in serotonin2A and GABA(A) receptors in schizophrenia: Studies on the human dorsolateral prefrontal cortex
10. No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia
11. Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors
12. Decrease of benzodiazepine receptors in frontal cortex of alcoholics
13. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls
14. Synaptic localization of striatal NMDA, quisqualate and kainate receptors
15. Central benzodiazepine receptor autoradiography in hippocampal sclerosis
16. Mechanism by which GABA, through its GABA(A) receptor, modulates glutamate release from rat cortical neurons in culture
17. Decreased number of benzodiazepine receptors in frontal cortex of rat brain following long-term lithium treatment
18. Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord
19. Autoradiographic comparison of the distribution of [3H]MK801 and [3H]CNQX in the human cerebellum during development and aging
20. Frontal lobe psychopathology: Mania, depression, confabulation, catatonia, perseveration, obsessive compulsions, and schizophrenia
21. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics
22. Psychiatric diagnosis after death: The problems of accurate diagnosis
23. Tissue pH as an indicator of mRNA preservation in human post-mortem brain
24. Brain imaging of affective disorders and schizophrenia
25. Alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: Minimal changes in postmortem brains of chronic schizophrenics
26. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: Neurochemical and clinical correlates
27. Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acid A receptor function
28. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics
29. Agonist and antagonist benzodiazepine receptor interaction in vitro
30. GABA and mood disorders: A brief review and hypothesis
31. Plasma GABA in affective illness. A preliminary investigation
32. [3H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging
33. Beyond lithium in the treatment of bipolar illness
34. Ontogeny of the benzodiazepine receptor in human brain: Fluorographic, immunochemical, and reversible binding studies
35. Mathematics and statistics of ligand assays
36. Alterations in phencyclidine and sigma binding sites in schizophrenic brains: Effects of disease process and neuroleptic medication
37. Tritiated LSD binding in frontal cortex in schizophrenia
38. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder
39. Benzodiazepine receptor sites in the human brain: Autoradiographic mapping
40. Decreased benzodiazepine binding with little effect on gamma-aminobutyric acid binding in rat brain after treatment with antisense oligodeoxynucleotide to the gamma-aminobutyric acid A receptor gamma-2 subunit